Fine-Tuning the JAK/STAT Pathway in Psoriasis: Safely Targeting the Underlying Mechanisms of Disease With TYK2 Inhibition
•Als PPT, PDF herunterladen•
0 gefällt mir•99 views
Co-Chairs, April W. Armstrong, MD, MPH, and Kenneth B. Gordon, MD, discuss psoriasis in this CME/MOC activity titled “Fine-Tuning the JAK/STAT Pathway in Psoriasis: Safely Targeting the Underlying Mechanisms of Disease With TYK2 Inhibition.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3dkgXl0. CME/MOC credit will be available until May 24, 2023.
